Canada OKs SYN X' traumatic brain injury tests:
This article was originally published in Clinica
SYN X Pharma has gained approval in Canada to sell serum-based test kits that measure what it claims are the first reliable biochemical markers of traumatic brain injury (TBI), such as Shaken Baby Syndrome. The Nexus Dx S-100 and Nexus Dx Neuron Specific Enolase (NSE) ELISA kits provide objective evidence of brain injury that will help physicians identify the Syndrome, allowing for child protection interventions, says the Toronto, Canada firm. SYN X is also developing a point-of-care TBI test.